• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Wednesday, January 15, 2020

    Time

    10:30 AM - 11:45 AM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1.25 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $30.00

    • Overview

      Fentanyl is 75-100 times more potent than oral morphine, leading transdermal fentanyl to be one of the most potent opioids. Recently inappropriate prescribing patterns of transdermal fentanyl has drastically increased, potentially causing life threatening errors. This presentation uses a particular dangerous case study to discuss the current trends of these inappropriate prescribing patterns. These trends include; prescribing to opiate naïve patients, incorrectly utilizing transdermal fentanyl in patients unable to take oral medications, and patients incorrectly labeled with codeine allergies. This presentation covers the necessary information to educate anyone on the appropriate criteria for prescribing transdermal fentanyl and will provide case-based scenarios to guide healthcare providers to manage inappropriate prescriptions.  


      Handouts

      Slide Document 19219L01_6pp.pdf
      Slide Document 19219L01_2pp.pdf





      Financial Support By

      PharmCon, Inc
    • Pharmacist

      Identify the risks associated with utilizing transdermal fentanyl.
      List the cytochrome P450 3A4 inhibitors that interact with transdermal fentanyl.
      Determine the correct treatment recommendations for transdermal fentanyl overdoses.
      Identify the recommended requirements for initiation or conversion to transdermal fentanyl.
      Identify which immediate release fentanyl products are registered under the FDA REMS program.
      List the 8 clinical pearls of prescribing transdermal fentanyl.
      List the 4 FDA recommendations and considerations for prescribing transdermal fentanyl released in the 2007 Health Care Advisory.

      Pharmacy Technician

      Identify the risks associated with utilizing transdermal fentanyl.
      Define the relative potency of transdermal fentanyl compared to oral morphine.
      Identify the recommended requirements for initiation or conversion to transdermal fentanyl.
      Identify which immediate release fentanyl products are registered under the FDA REMS program.
      List the 4 FDA recommendations and considerations for prescribing transdermal fentanyl released in the 2007 Health Care Advisory.
      List the 8 clinical pearls of prescribing transdermal fentanyl.

      Nurse

      Identify the risks associated with utilizing transdermal fentanyl.
      List the cytochrome P450 3A4 inhibitors that interact with transdermal fentanyl.
      Determine the correct treatment recommendations for transdermal fentanyl overdoses.
      Identify the recommended requirements for initiation or conversion to transdermal fentanyl.
      Identify which immediate release fentanyl products are registered under the FDA REMS program.
      List the 8 clinical pearls of prescribing transdermal fentanyl.
      List the 4 FDA recommendations and considerations for prescribing transdermal fentanyl released in the 2007 Health Care Advisory.
    • Repeat Presentation

      This presentation was last given on 6/4/2020 8:00 PM

      Future Airings

      Date Time
      Friday, March 20, 2020 2:00 PM View
      Saturday, May 16, 2020 11:30 AM View
      Thursday, June 4, 2020 8:00 PM View
      Saturday, July 25, 2020 11:30 AM View

    • Activity Type

      Application

      CE Broker

      20-759934

      Universal Activity Number

      Pharmacist 0798-0000-19-219-L01-P

      Pharmacy Technician 0798-0000-19-219-L01-T

      Nurse 0798-0000-19-219-L01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.